News from nora therapeutics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 28, 2014, 11:55 ET

Nora Therapeutics to Present at Upcoming Conferences in June

 Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today...

Apr 17, 2014, 05:30 ET

Nora Therapeutics Announces $18 Million Series B Financing

 Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, today announced...

Mar 27, 2014, 08:30 ET

Nora Therapeutics Expands Board of Directors with Appointment of Dennis M. Fenton

Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, today announced that...

Mar 21, 2014, 08:30 ET

Nora Therapeutics to Present at the 21st Annual Future Leaders in the Biotech Industry Conference

 Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today...

Mar 04, 2014, 08:00 ET

Nora Therapeutics to Present at 26th Annual ROTH Conference

Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today that...

Feb 05, 2014, 08:00 ET

Nora Therapeutics to Present at Upcoming Conferences in February

 Nora Therapeutics, a biotechnology company focused on developing therapeutics to address unmet needs in reproductive medicine, announced today...

Dec 06, 2013, 18:03 ET

Nora Therapeutics Announces New Time for Presentation at the Oppenheimer 24th Annual Healthcare Conference

 Nora Therapeutics announced today that CEO Jeffrey K. Tong, Ph.D., will present at the Oppenheimer 24th Annual Healthcare Conference. The...

Dec 02, 2013, 08:00 ET

Nora Therapeutics to Present at the Oppenheimer 24th Annual Healthcare Conference

Nora Therapeutics announced today that CEO Jeffrey K. Tong, Ph.D., will present at the Oppenheimer 24th Annual Healthcare Conference. The...

Nov 05, 2013, 08:17 ET

Main Line Fertility Participates In The Thrive-IVF Research Study To Help Improve Pregnancy Success Rates And Outcomes In Women With A History Of Repeated In Vitro Fertilization (IVF) Failures

 Main Line Fertility today announced its participation in the Thrive-IVF Research Study, a Phase 2 clinical trial sponsored by Nora...

Sep 26, 2013, 08:28 ET

Center Of Reproductive Medicine Participates In The Thrive-IVF Research Study To Help Improve Pregnancy Success Rates And Outcomes In Women With A History Of Repeated In Vitro Fertilization (IVF) Failures

 The Center of Reproductive Medicine today announced its participation in the Thrive-IVF Research Study, a Phase 2 clinical trial sponsored by...

Sep 26, 2013, 08:17 ET

Houston Fertility Institute Participates In The Thrive-IVF Research Study To Help Improve Pregnancy Success Rates And Outcomes In Women With A History Of Repeated In Vitro Fertilization (IVF) Failures

 Houston Fertility Institute today announced its participation in the Thrive-IVF Research Study, a Phase 2 clinical trial sponsored by Nora...

Sep 12, 2013, 08:17 ET

Georgia Reproductive Specialists Participates In The Thrive-IVF Research Study To Help Improve Pregnancy Success Rates And Outcomes In Women With A History Of Repeated In Vitro Fertilization (IVF) Failures

 Georgia Reproductive Specialists today announced its participation in the Thrive-IVF Research Study, a Phase 2 clinical trial sponsored by...

Aug 20, 2013, 09:17 ET

Florida Fertility Institute Participates In The Thrive-IVF Research Study To Help Improve Pregnancy Success Rates And Outcomes In Women With A History Of Repeated In Vitro Fertilization (IVF) Failures

 Florida Fertility Institute today announced its participation in the Thrive-IVF Research Study, a Phase 2 clinical trial sponsored by Nora...